Nearly a decade of Drugs to Watch

Review the history of drugs identified as potential blockbusters

Download Drugs to Watch 2021

Annually since January 2013, the Clarivate expert team has analyzed and selected the Drugs to Watch. While the underlying process has remained the same, the technologies have evolved, and new tools, such as Drug Timelines & Success Rates, are now available to inform the analysis.

Learn more about our methods

Drug Name Company Therapy Area Year
Ertugliflozin (Steglatro) Merck & Co., Pfizer Inc. Endocrinology/metabolic disease 2018
Evolocumab (Repatha) Amgen, Astellas Pharma Inc. Cardiovascular disease 2015
Filgotinib (GLPG-0634) Galapagos NV, Gilead Sciences Inc. Excessive immune response/autoimmunity 2020
Fluticasone furoate plus vilanterol trifenatate (Relovair) GlaxoSmithKline plc, Theravance Biopharma Inc. Respiratory disease 2013
Gardasil 9 vaccine Merck & Co. Infectious disease 2015
Grazoprevir plus elbasvir (MK-5172A) Merck & Co. Infectious disease 2016
Icosapent ethyl ester (Vascepa) Amarin Corporation plc Cardiovascular disease 2013
Idelalisib (Zydelig) Gilead Sciences Inc. Oncology 2014
Inclisiran (ALN-PCSsc; ALN-60212; PCSK9si; Leqvio) The Medicines Co. Cardiovascular disease 2020
Insulin glargine (Toujeo) Sanofi SA Endocrinology/metabolic disease 2015
Lanadelumab (Takhzyro) Shire Genetic disorder 2018
Lisocabtagene maraleucel (JCAR-017; Liso-cel) Celgene Corporation Oncology 2020
Lumacaftor plus ivacaftor (Orkambi) Vertex Pharmaceuticals Inc. Respiratory disease 2015
Niraparib (Zejula) Tesaro Oncology 2017
Nivolumab (Opdivo) Bristol-Myers Squibb Co. Oncology 2015
Obeticholic acid (Ocaliva) Intercept Pharmaceuticals, Sumitomo Dainippon Pharma Hepatology 2016
Ocrelizumab (Ocrevus) Roche Neurology/psychiatric 2017
Ofatumumab (OMB-157; Kesimpta) Novartis International AG Neurology/psychiatric 2020
Onasemnogene abeparvovec (AVXS-101; Zolgensma) AveXis Genetic disorder 2019

From innovation to bottom line

Access our global intelligence, advanced analytics and global team of experts.

Contact our team